Pancreatic Cancer Research

ResearcherNational Institutes of HealthActive in the last 2 years

Steven Rosenberg

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8939-8910; OpenAlex author ID A5072133376; NIH RePORTER profile ID 9692361. Sources: ClinicalTrials.gov.

Their work

Papers
3 (first author 1, last author 0)
Trials
8 (principal investigator on 7)
Grants
1
Labs led
0
Collaborators
8
Papers, trials and grants by year

2005: 1 trial · 2006: 1 trial · 2007: none · 2008: none · 2009: none · 2010: 1 trial · 2011: none · 2012: 2 trials · 2013: none · 2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: 2 trials · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 trial · 2024: none · 2025: 1 grant

Papers 3

  1. Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer. Co-author DOI 10.1056/nejmoa2119662↗
  2. A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer. Co-author DOI 10.1089/hum.2013.209↗
  3. Pancreatic cancer: Hurdles in the engineering of CAR-based immunotherapies. First author DOI 10.4161/onci.29194↗

Trials 8

  1. Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment Principal investigator NCT05600933↗
  2. Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer Principal investigator NCT03300843↗
  3. Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy Principal investigator NCT03407040↗
  4. CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer Principal investigator NCT01583686↗
  5. Collecting Solid Tumor Tissue to Identify New Treatments Principal investigator NCT01658917↗
  6. Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer Principal investigator NCT01174121↗
  7. Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer Study chair NCT00436410↗
  8. MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery Principal investigator NCT00112580↗

Grants 1

  1. Adoptive Cell Transfer Immunotherapy of Cancer ZIABC010984↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eric Tran · 2 shared papers, 2014–2022 · strength 0.17
  2. Rom S. Leidner · 1 shared paper, 2022 · strength 0.13
  3. Daniel Abate‐Daga · 2 shared papers, 2014 · strength 0.11
  4. Richard A. Morgan · 1 shared paper, 2014 · strength 0.07
  5. Yaroslav Teper · 1 shared paper, 2014 · strength 0.04
  6. William R. Burns · 1 shared paper, 2014 · strength 0.04
  7. Richard A. Morgan · 1 shared paper, 2014 · strength 0.04
  8. Udo Rudloff · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.